CYTOR and breast cancer: For example, linc00152 is deregulated during breast cancer progression.21 Triple‐negative breast cancer is a type of basal‐like breast cancer, whose development is related to the suppressive effect of linc00152 on BRCA1/PTEN via mammalian DNA methyltransferase.36